Vitamin D in African Americans with multiple sclerosis

J. M. Gelfand, B. A C Cree, J. McElroy, J. Oksenberg, Ralph Green, E. M. Mowry, J. W. Miller, S. L. Hauser, A. J. Green

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Objective: To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans. Methods: Serum 25-hydroxyvitamin D was compared in a cross-sectional sample of 339 African Americans with MS and 342 African American controls. Correlations between disease severity (Multiple Sclerosis Severity Score [MSSS]) and 25-hydroxyvitamin D levels were sought. Results: A total of 71% of controls and 77% of patients with MS were vitamin D deficient (<50 nmol/L; <20 ng/mL), and 93% of controls and 94% of patients with MS were vitamin D insufficient (<75 nmol/L; <30 ng/mL). Median unadjusted (29.7 vs 36.6 nmol/L, p = 0.0001) and deseasonalized (p = 0.0013) 25-hydroxyvitamin D levels were lower in the MS group. Multivariable analysis revealed that differences in latitude and ultraviolet index accounted for much of this association. The median (interquartile range) MSSS was 6.1 (4.8-8.1). There was no apparent association between the MSSS and vitamin D status. A greater proportion of European genetic ancestry, a measure of genetic admixture, was positively correlated with 25-hydroxyvitamin D (p = 0.007). Conclusions: Levels of 25-hydroxyvitamin D were lower in African Americans with MS than controls, an observation primarily explained by differences in climate and geography. There was no apparent association between vitamin D status and disease severity. These results are consistent with observations in other populations that lower 25-hydroxyvitamin D is associated with having MS, but also highlight the importance of climate and ancestry in determining vitamin D status.

Original languageEnglish (US)
Pages (from-to)1824-1830
Number of pages7
JournalNeurology
Volume76
Issue number21
DOIs
StatePublished - May 24 2011

Fingerprint

Vitamin D
African Americans
Multiple Sclerosis
Climate
Geography
25-hydroxyvitamin D
Observation
Serum

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Gelfand, J. M., Cree, B. A. C., McElroy, J., Oksenberg, J., Green, R., Mowry, E. M., ... Green, A. J. (2011). Vitamin D in African Americans with multiple sclerosis. Neurology, 76(21), 1824-1830. https://doi.org/10.1212/WNL.0b013e31821cccf5

Vitamin D in African Americans with multiple sclerosis. / Gelfand, J. M.; Cree, B. A C; McElroy, J.; Oksenberg, J.; Green, Ralph; Mowry, E. M.; Miller, J. W.; Hauser, S. L.; Green, A. J.

In: Neurology, Vol. 76, No. 21, 24.05.2011, p. 1824-1830.

Research output: Contribution to journalArticle

Gelfand, JM, Cree, BAC, McElroy, J, Oksenberg, J, Green, R, Mowry, EM, Miller, JW, Hauser, SL & Green, AJ 2011, 'Vitamin D in African Americans with multiple sclerosis', Neurology, vol. 76, no. 21, pp. 1824-1830. https://doi.org/10.1212/WNL.0b013e31821cccf5
Gelfand JM, Cree BAC, McElroy J, Oksenberg J, Green R, Mowry EM et al. Vitamin D in African Americans with multiple sclerosis. Neurology. 2011 May 24;76(21):1824-1830. https://doi.org/10.1212/WNL.0b013e31821cccf5
Gelfand, J. M. ; Cree, B. A C ; McElroy, J. ; Oksenberg, J. ; Green, Ralph ; Mowry, E. M. ; Miller, J. W. ; Hauser, S. L. ; Green, A. J. / Vitamin D in African Americans with multiple sclerosis. In: Neurology. 2011 ; Vol. 76, No. 21. pp. 1824-1830.
@article{8dccb366a5e94c7c9056129b7c1467e7,
title = "Vitamin D in African Americans with multiple sclerosis",
abstract = "Objective: To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans. Methods: Serum 25-hydroxyvitamin D was compared in a cross-sectional sample of 339 African Americans with MS and 342 African American controls. Correlations between disease severity (Multiple Sclerosis Severity Score [MSSS]) and 25-hydroxyvitamin D levels were sought. Results: A total of 71{\%} of controls and 77{\%} of patients with MS were vitamin D deficient (<50 nmol/L; <20 ng/mL), and 93{\%} of controls and 94{\%} of patients with MS were vitamin D insufficient (<75 nmol/L; <30 ng/mL). Median unadjusted (29.7 vs 36.6 nmol/L, p = 0.0001) and deseasonalized (p = 0.0013) 25-hydroxyvitamin D levels were lower in the MS group. Multivariable analysis revealed that differences in latitude and ultraviolet index accounted for much of this association. The median (interquartile range) MSSS was 6.1 (4.8-8.1). There was no apparent association between the MSSS and vitamin D status. A greater proportion of European genetic ancestry, a measure of genetic admixture, was positively correlated with 25-hydroxyvitamin D (p = 0.007). Conclusions: Levels of 25-hydroxyvitamin D were lower in African Americans with MS than controls, an observation primarily explained by differences in climate and geography. There was no apparent association between vitamin D status and disease severity. These results are consistent with observations in other populations that lower 25-hydroxyvitamin D is associated with having MS, but also highlight the importance of climate and ancestry in determining vitamin D status.",
author = "Gelfand, {J. M.} and Cree, {B. A C} and J. McElroy and J. Oksenberg and Ralph Green and Mowry, {E. M.} and Miller, {J. W.} and Hauser, {S. L.} and Green, {A. J.}",
year = "2011",
month = "5",
day = "24",
doi = "10.1212/WNL.0b013e31821cccf5",
language = "English (US)",
volume = "76",
pages = "1824--1830",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "21",

}

TY - JOUR

T1 - Vitamin D in African Americans with multiple sclerosis

AU - Gelfand, J. M.

AU - Cree, B. A C

AU - McElroy, J.

AU - Oksenberg, J.

AU - Green, Ralph

AU - Mowry, E. M.

AU - Miller, J. W.

AU - Hauser, S. L.

AU - Green, A. J.

PY - 2011/5/24

Y1 - 2011/5/24

N2 - Objective: To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans. Methods: Serum 25-hydroxyvitamin D was compared in a cross-sectional sample of 339 African Americans with MS and 342 African American controls. Correlations between disease severity (Multiple Sclerosis Severity Score [MSSS]) and 25-hydroxyvitamin D levels were sought. Results: A total of 71% of controls and 77% of patients with MS were vitamin D deficient (<50 nmol/L; <20 ng/mL), and 93% of controls and 94% of patients with MS were vitamin D insufficient (<75 nmol/L; <30 ng/mL). Median unadjusted (29.7 vs 36.6 nmol/L, p = 0.0001) and deseasonalized (p = 0.0013) 25-hydroxyvitamin D levels were lower in the MS group. Multivariable analysis revealed that differences in latitude and ultraviolet index accounted for much of this association. The median (interquartile range) MSSS was 6.1 (4.8-8.1). There was no apparent association between the MSSS and vitamin D status. A greater proportion of European genetic ancestry, a measure of genetic admixture, was positively correlated with 25-hydroxyvitamin D (p = 0.007). Conclusions: Levels of 25-hydroxyvitamin D were lower in African Americans with MS than controls, an observation primarily explained by differences in climate and geography. There was no apparent association between vitamin D status and disease severity. These results are consistent with observations in other populations that lower 25-hydroxyvitamin D is associated with having MS, but also highlight the importance of climate and ancestry in determining vitamin D status.

AB - Objective: To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans. Methods: Serum 25-hydroxyvitamin D was compared in a cross-sectional sample of 339 African Americans with MS and 342 African American controls. Correlations between disease severity (Multiple Sclerosis Severity Score [MSSS]) and 25-hydroxyvitamin D levels were sought. Results: A total of 71% of controls and 77% of patients with MS were vitamin D deficient (<50 nmol/L; <20 ng/mL), and 93% of controls and 94% of patients with MS were vitamin D insufficient (<75 nmol/L; <30 ng/mL). Median unadjusted (29.7 vs 36.6 nmol/L, p = 0.0001) and deseasonalized (p = 0.0013) 25-hydroxyvitamin D levels were lower in the MS group. Multivariable analysis revealed that differences in latitude and ultraviolet index accounted for much of this association. The median (interquartile range) MSSS was 6.1 (4.8-8.1). There was no apparent association between the MSSS and vitamin D status. A greater proportion of European genetic ancestry, a measure of genetic admixture, was positively correlated with 25-hydroxyvitamin D (p = 0.007). Conclusions: Levels of 25-hydroxyvitamin D were lower in African Americans with MS than controls, an observation primarily explained by differences in climate and geography. There was no apparent association between vitamin D status and disease severity. These results are consistent with observations in other populations that lower 25-hydroxyvitamin D is associated with having MS, but also highlight the importance of climate and ancestry in determining vitamin D status.

UR - http://www.scopus.com/inward/record.url?scp=79958124650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958124650&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31821cccf5

DO - 10.1212/WNL.0b013e31821cccf5

M3 - Article

C2 - 21606454

AN - SCOPUS:79958124650

VL - 76

SP - 1824

EP - 1830

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 21

ER -